市場調査レポート

商品コード

1593468

生検装置の市場規模、シェア、成長分析、製品別、ガイダンス技術別、用途別、最終用途別、地域別：2024年～2031年産業予測

Biopsy Devices Market Size, Share, Growth Analysis, By Product, By Guidance Technique, By Application, By End Use, By Region - Industry Forecast 2024-2031

出版日: 2024年11月13日
発行: SkyQuest
ページ情報: 英文 193 Pages
納期: 3～5営業日

価格

PDF & Excel (Single User License)

USD 5,300 760,921円

レポートPDF・Excelを1 名様のみがご利用頂けるライセンスです。PDF・Excell内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します

PDF & Excel (Multiple User License)

USD 6,200 890,134円

レポートPDF・Excel2-5名様までがご利用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

PDF & Excel (Enterprise License)

USD 7,100 1,019,347円

レポートPDF・Excelを同一企業に所属の全世界の方にご使用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=143.57円

全表示
概要
目次

概要

サンプル依頼リストに入れる

生検装置の世界市場規模は、2022年に57億9,000万米ドルと評価され、2023年の66億米ドルから2031年には188億3,000万米ドルに成長し、予測期間（2024-2031年）のCAGRは14.00%で成長する見通しです。

生検市場は、特に乳がん、前立腺がん、肺がんなどのがん罹患率の上昇と生検技術の進歩によって大きな成長を遂げています。セリアック病や悪性腫瘍などの診断に不可欠なこの手術手技は、主に放射線科医、外科医、介入心臓専門医によって、さまざまな臓器に合わせた専用の器具を用いて行われます。CTスキャン、MRI、超音波などの画像技術の革新は、生検の精度と最小限の侵襲性を高め、3D光学生検やMRIターゲット生検のような、より洗練された方法の採用につながっています。これらのツールの統合により、特に肝臓、腎臓、肺などのより効率的な臓器生検が促進されています。慢性疾患の検出に関する意識の高まりも、定位ガイド下生検などの高度な技術の台頭に寄与しています。しかし、生検装置に関連する高コストや新興国地域における有資格のヘルスケア専門家の不足などの課題に直面しており、これが市場のさらなる拡大を妨げる可能性があります。全体として、進化する生検技術の情勢は、がんやその他の慢性疾患の負担が増加する中、医療従事者が診断精度の向上と患者の転帰の改善を求めていることから、大きな成長機会をもたらしています。

市場概要
液体生検器具
針式生検器具
- コア生検装置
- コア生検針
- コア生検ガン
- 吸引生検針
- 真空アシスト生検装置
- 真空アシスト生検システム
- 真空補助生検針
処置トレイ
ローカリゼーションワイヤー
生検テーブル
生検鉗子
- 一般的な生検鉗子
- ホット生検鉗子
その他の製品

生検装置市場：ガイダンス技術別

市場概要
非画像誘導生検
画像誘導生検
- 超音波ガイド下生検
- 定位ガイド下生検
- MRIガイド下生検
- その他の画像誘導生検技術

生検装置市場：用途別

市場概要
肺がん
乳がん
大腸がん
腎臓がん
前立腺がん
骨髄生検
その他の用途

生検装置市場：エンドユーザー別

市場概要
病院と乳がんケアセンター
画像診断センター
学術調査機関
その他のエンドユーザー

生検装置市場：地域別

市場概要
北米
- 米国
- カナダ
欧州
- ドイツ
- スペイン
- フランス
- 英国
- イタリア
- その他欧州地域
アジア太平洋地域
- 中国
- インド
- 日本
- 韓国
- その他アジア太平洋地域
ラテンアメリカ
- ブラジル
- その他ラテンアメリカ地域
中東・アフリカ（MEA）
- GCC諸国
- 南アフリカ
- その他中東・アフリカ地域

競合情勢

上位5社の比較
主要企業の市場ポジショニング（2023年）
主な市場企業が採用した戦略
市場における最近の活動
主要企業の市場シェア（2023年）

主要企業プロファイル

Becton, Dickinson and Company（US）
Danaher Corporation（US）
B. Braun Melsungen AG（Germany）
Cardinal Health, Inc.（US）
Hologic, Inc.（US）
Olympus Corporation（Japan）
Boston Scientific Corporation（US）
Fujifilm Corporation（Japan）
Medtronic Plc（Ireland）
Stryker Corporation（US）
Cook Group Incorporated（US）
Argon Medical Devices（US）
Inrad, Inc.（US）
Conmed Corporation（US）
Teleflex Incorporated（US）
Qiagen N.V.（Netherlands）
Thermo Fisher Scientific, Inc.（US）
Summit Medical LLC（US）
Hill-Rom Holdings, Inc.（US）
Gallini S.R.L（Italy）
Transmed7, LLC（US）
TSK Laboratory International（Japan）
Merit Medical Systems, Inc.（US）
DR. Japan Co., Ltd.（Japan）
IZI Medical Products（US）
Planmed Oy（Finland）
Advin Health Care（India）
F. Hoffmann-La Roche Ltd.（Switzerland）
Bio-Rad Laboratories, Inc.（US）
Illumina, Inc.（US）

Product Code: SQMIG35A2955

Global Biopsy Devices Market size was valued at USD 5.79 billion in 2022 and is poised to grow from USD 6.60 billion in 2023 to USD 18.83 billion by 2031, growing at a CAGR of 14.00% in the forecast period (2024-2031).

The biopsy market is experiencing significant growth driven by a rise in cancer prevalence-particularly in breast, prostate, and lung cancers-and advancements in biopsy technologies. This surgical technique, essential in diagnosing conditions such as coeliac disease and malignancies, is primarily performed by radiologists, surgeons, and interventional cardiologists using specialized instruments tailored to various organs. Innovations in imaging technologies, including CT scans, MRIs, and ultrasound, are enhancing the precision and minimal invasiveness of biopsies, leading to the adoption of more sophisticated methods like 3D optical and MRI-targeted biopsies. The integration of these tools is facilitating more efficient organ biopsies, particularly for the liver, kidneys, and lungs. Increasing awareness around chronic disease detection is also contributing to the rise of advanced techniques, such as stereotactic-guided biopsies. However, the market faces challenges, including the high costs associated with biopsy devices and a shortage of qualified healthcare professionals in developing regions, which may impede further market expansion. Overall, the evolving landscape of biopsy technologies presents significant opportunities for growth, as healthcare providers seek to improve diagnostic accuracy and patient outcomes amidst the rising burden of cancer and other chronic diseases.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Biopsy Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Biopsy Devices Market Segmental Analysis

Global Biopsy Devices Market is segmented on the product, guidance technique, application, end user, and region. By Product, Market is segmented into Liquid Biopsy Instruments, Needle-Based Biopsy Instruments, Procedure Trays, Localization Wires, Biopsy Tables, Biopsy Forceps, and Other Products. By Guidance Technique, Market for biopsy procedures is segmented into Non-Image-Guided Biopsy and Image-Guided Biopsy techniques. By Application, market is segmented into Lung Cancer, Breast Cancer, Colorectal Cancer, Kidney Cancer, Prostate Cancer, Bone Marrow Biopsy, and Other Applications. By End User, the Market is segmented into Hospitals & Breast Care Centers, Diagnostic Imaging Centers, Academic & Research Institutes, and Other End Users. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Driver of the Global Biopsy Devices Market

The global biopsy devices market is notably propelled by the alarming rise in cancer incidence across various demographics and regions. As cancer cases continue to escalate, the demand for accurate and early diagnostic methodologies becomes paramount for effective treatment and management. This heightened awareness of early detection is fostering a significant uptick in biopsy procedures, thus driving innovation and advancements in biopsy technologies. The market is witnessing a surge in the development of sophisticated biopsy devices designed to enhance precision, reduce patient discomfort, and improve diagnostic outcomes, ultimately shaping a robust landscape for future growth in the biopsy devices sector.

Restraints in the Global Biopsy Devices Market

The Global Biopsy Devices market faces a significant restraint in the form of limited access to advanced biopsy technologies, particularly in developing regions. Economic constraints and underdeveloped healthcare infrastructure inhibit the availability and adoption of state-of-the-art biopsy instruments, resulting in a disparity in healthcare quality. This restricted access not only curtails market penetration but also impacts patient outcomes, as many individuals in these regions may remain undiagnosed or receive suboptimal care. Consequently, this gap in accessibility poses a challenge to market expansion and innovation, stifling the potential growth of biopsy device manufacturers looking to enter diverse global markets.

Market Trends of the Global Biopsy Devices Market

The Global Biopsy Devices market is experiencing a significant trend towards the adoption of image-guided biopsy techniques, driven by advancements in imaging technologies such as ultrasound and CT scan guidance. These techniques offer real-time imaging capabilities that enhance the precision and accuracy of biopsy procedures, resulting in improved patient outcomes and diagnostic accuracy. As healthcare providers increasingly prioritize minimally invasive methods and precise interventions, the demand for sophisticated biopsy devices has surged. This growing preference for image-guided approaches is set to propel market growth, reflecting a broader shift towards innovation and technology-driven solutions in the medical field.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Key Success Factor
Degree of Competition
Top Investment Pockets
Ecosystem of the Market
Value Chain Analysis
Supply Chain Analysis
Patent Analysis
Trade Analysis
Customer & Buying Criteria Analysis
Technology Analysis
Case Study Analysis
Pricing Analysis

Biopsy Devices Market, By Product

Market Overview
Liquid Biopsy Instruments
Needle-Based Biopsy Instruments
- Core Biopsy Devices
- Core Biopsy Needles
- Core Biopsy Guns
- Aspiration Biopsy Needles
- Vacuum-Assisted Biopsy Devices
- Vacuum-Assisted Biopsy Systems
- Vacuum-Assisted Biopsy Needles
Procedure Trays
Localization Wires
Biopsy Tables
Biopsy Forceps
- General Biopsy Forceps
- Hot Biopsy Forceps
Other Products

Biopsy Devices Market, By Guidance Technique

Market Overview
Non-Image-Guided Biopsy
Image-Guided Biopsy
- Ultrasound-Guided Biopsy
- Stereotactic-Guided Biopsy
- Mri-Guided Biopsy
- Other Image-Guided Biopsy Techniques

Biopsy Devices Market, By Application

Market Overview
Lung Cancer
Breast Cancer
Colorectal Cancer
Kidney Cancer
Prostate Cancer
Bone Marrow Biopsy
Other Applications

Biopsy Devices Market, By End User

Market Overview
Hospitals & Breast Care Centers
Diagnostic Imaging Centers
Academic & Research Institutes
Other End Users

Biopsy Devices Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2023

Key Company Profiles

Becton, Dickinson and Company (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Danaher Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
B. Braun Melsungen AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cardinal Health, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hologic, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Olympus Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boston Scientific Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fujifilm Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medtronic Plc (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Stryker Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cook Group Incorporated (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Argon Medical Devices (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Inrad, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Conmed Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Teleflex Incorporated (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Qiagen N.V. (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Summit Medical LLC (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hill-Rom Holdings, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Gallini S.R.L (Italy)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Transmed7, LLC (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
TSK Laboratory International (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merit Medical Systems, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
DR. Japan Co., Ltd. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
IZI Medical Products (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Planmed Oy (Finland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Advin Health Care (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
F. Hoffmann-La Roche Ltd. (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Illumina, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments